When T cells are activated via the T cell receptor (TCR) complex a number of cellular substrates, including some cell surface proteins, become phosphorylated on tyrosine (Tyr) residues. Phosphorylation of cytoplasmic Tyr renders these cell surface receptors competent to interact with proteins that link cell surface receptors to protein in the intracellular signaling pathways. Here we show that Tyr residues in the cytoplasmic domain of CD6 become phosphorylated upon T cell activation via the TCR complex. Tyr phosphorylation was observed when the T cells were activated by crosslinking CD3 or by cocrosslinking CD3 with CD2 or CD4, but not when the cells were stimulated by crosslinking CD2, CD4, or CD28 alone. Unlike other Tyr kinase substrates, such as the phospholipase C gamma 1-associated pp35/36 protein, whose level of Tyr phosphorylation is highest when T cells are activated by cocrosslinking CD3 with CD2, the levels of CD6 Tyr phosphorylation are highest when T cells were activated by cocrosslinking CD3 with CD4.
Skip Nav Destination
Article navigation
1 January 1993
Article|
January 01 1993
Tyrosine phosphorylation of CD6 by stimulation of CD3: augmentation by the CD4 and CD2 coreceptors.
S Wee,
S Wee
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
Search for other works by this author on:
G L Schieven,
G L Schieven
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
Search for other works by this author on:
J M Kirihara,
J M Kirihara
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
Search for other works by this author on:
T T Tsu,
T T Tsu
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
Search for other works by this author on:
J A Ledbetter,
J A Ledbetter
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
Search for other works by this author on:
A Aruffo
A Aruffo
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
Search for other works by this author on:
S Wee
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
G L Schieven
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
J M Kirihara
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
T T Tsu
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
J A Ledbetter
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
A Aruffo
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1993) 177 (1): 219–223.
Citation
S Wee, G L Schieven, J M Kirihara, T T Tsu, J A Ledbetter, A Aruffo; Tyrosine phosphorylation of CD6 by stimulation of CD3: augmentation by the CD4 and CD2 coreceptors.. J Exp Med 1 January 1993; 177 (1): 219–223. doi: https://doi.org/10.1084/jem.177.1.219
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement